PDMR / PCA dealings
One Health Group plc
("One Health", the "Company" or the "Group")
PDMR / PCA dealings
One Health Group plc (AIM: OHGR), the independent provider of NHS-funded surgical procedures for patients referred from the NHS through 'Patient Choice', announces that One Health Group Trustees LLP, the trustee of the One Health Group Employee Benefit Trust, has notified the Company that it has sold its entire holding of 292,345 Ordinary Shares at a price of 246.5 pence per share to satisfy demand from new institutional investors.
Further details of the Ordinary Shares sold by the One Health Group Trustees LLP are set out below.
If you wish to keep up to date on Company news please email: onehealth@walbrookpr.com
For more information, please contact:
One Health Group plc
Derek Bickerstaff, Chairman
Adam Binns, CEO
Via Walbrook PR
Panmure Liberum (Nominated Adviser and Broker)
Emma Earl, Will Goode, Mark Rogers
Rupert Dearden
Tel: +44 (0)20 3100 2000
Walbrook PR (Media & Investor Relations)
Alice Woodings / Paul McManus /
Rachel Broad
Tel: +44 (0)20 7933 8780 or onehealth@walbrookpr.com
Mob: +44 (0)7407 804 654 / +44 (0)7980 541 893 /
+44 (0)7747 515 393
About One Health Group plc (www.onehealth.co.uk)
One Health engages 80 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and, in the year, to March 2025 provided much needed care to 17,020 new patients, through over 42,000 consultations and over 7,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 9 independent hospitals and 37 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. Currently, the Company's activities are focused in Yorkshire, Lincolnshire, Derbyshire, Nottinghamshire and Leicestershire. Revenue is derived from over 60 NHS commissioning bodies in addition to contracts with local NHS Hospital Trusts to transfer their internal waiting list patients to One Health for quicker treatment.
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology, with urology introduced at the end of FY25.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
Online investor presentation
Click below for the latest online presentation by Derek Bickerstaff, Chairman and Adam Binns, Chief Executive Officer, which offers insights into the Company's growth strategy and long-term vision:
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
One Health Group Trustees LLP
2
Reason for the notification
a)
Position/status
Person closely associated with Derek
Bickerstaff, Non-Executive Chairman and Adam Binns, Chief Executive
b)
Initial notification/Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
One Health Group plc
b)
LEI
984500DC689F5BAD8732
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Ordinary Shares of 0.5 pence each
Identification code
GB00BNNT0595
b)
Nature of the transaction
Sale of Ordinary Shares
c)
Price(s) and volumes(s)
Price(s)
Volume(s)
246.5 pence
292,345
d)
Aggregated information
Aggregated volume
292,345
Price
246.5 pence
e)
Date of the transaction
9 July 2026
f)
Place of the transaction
London Stock Exchange
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHEADXNESAKEFA
